Jessica Johnson

Jessica Johnson, DNP, APRN, PMHNP-BC, is a Clinical Instructor of Child Psychiatric Nursing at Yale School of Medicine’s Child Study Center. She holds affiliations with Yale Medicine and contributes to clinical research in pediatric psychiatric disorders.

Education: DNP in Psychiatric-Mental Health Nursing from Columbia University (2021), MSN from Columbia (2019), and BS in Psychology/Neuroscience from Syracuse University (2016). Board Certified in Psychiatric/Mental Health Nursing (ANCC, 2021).

Research Interests

Her work focuses on pediatric psychiatric disorders, including obsessive-compulsive disorder (OCD), treatment-resistant depression, ADHD, and Tourette’s Syndrome. She investigates pharmacological interventions, treatment response criteria, and clinical trial methodologies. Key areas include cannabinoid therapies, ketamine’s role in mood disorders, and meta-analyses of antidepressant efficacy and side effects.

Publications Overview

Her research spans OCD treatment protocols (2021), ketamine’s efficacy in adolescents (2021), and SSRIs/SNRIs dose-response curves (2018). She also explores long-term behavioral outcomes in ADHD (2017) and antipsychotic efficacy for irritability (2017). Her work emphasizes translational research bridging clinical practice and pediatric mental health innovations.

Collaborations & Labs

Active collaborations include work with Michael Bloch, MD, MS, and the Child Study Center team. Her research is grounded in interdisciplinary approaches to child psychiatric care.